This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Laboratorios Salvat, S.a.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Ester Monlleó Mas: Innovator in Pharmaceutical Development
Introduction
Ester Monlleó Mas is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target apoptotic processes. Her work is essential for advancing treatments for various pathological conditions.
Latest Patents
Ester holds a patent for Apaf-1 inhibitor compounds. The patent describes derivatives of 2,5-piperazinedione that act as inhibitors of apoptotic peptidase activating factor 1 (Apaf-1). These compounds are valuable as active pharmaceutical ingredients for the prophylaxis and treatment of conditions associated with increased apoptosis. This innovation highlights her commitment to addressing critical health issues through scientific research.
Career Highlights
Ester is currently employed at Laboratorios Salvat, S.A., where she continues to develop innovative pharmaceutical solutions. Her expertise in the field has positioned her as a key player in the industry, contributing to the advancement of medical treatments.
Collaborations
Ester has collaborated with notable colleagues, including Ángel Messeguer Peypoch and Alejandra Moure Fernández. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Ester Monlleó Mas exemplifies the spirit of innovation in the pharmaceutical industry. Her work on Apaf-1 inhibitors demonstrates her dedication to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile